The summer has been wrought with hardship for pharmaceutical giant AstraZeneca, and the company has decided to put its U.S. headquarters up for sale. Located in Fairfax, Delaware, the...
It’s not easy for patients to manage their risk of blood clots. Popular blood thinners come with some staggering bleeding risks and newer anticoagulants don’t have antidotes available to...
Healthcare giant Johnson & Johnson (J&J) and its subsidiary Ethicon have just announced a partnership with health technology company Touch Surgery. The companies will work together to create a...
For people with severe allergies, epinephrine injectors like the EpiPen are a lifeline in dire situations. Living without an EpiPen nearby is risky, but paying for the little injectors...
We trust our doctors to select the right medication to treat our illnesses and conditions. But do doctors always live up to this expectation? A new study published in...
The U.S. Food and Drug Administration (FDA) takes a lot of criticism, but in its defense, the agency lacks the funding and manpower to address many expressed concerns. But...
It’s not easy being the U.S. Food and Drug Administration (FDA). The agency must straddle a fine line between approving lifesaving medical treatments and protecting consumers from harmful products....
3D Printed medical devices are a new frontier in healthcare, and the FDA is struggling to understand the best way to regulate them. This past May, the agency released...
Johnson & Johnson’s blockbuster rheumatoid arthritis drug Remicade will now be competing with a cheaper biosimilar. Just last week, a judge ruled the patent protecting the medication was invalid,...
While most people would consider a death to be just that – a death, medical device manufacturers seem to disagree. Thousands of deaths caused by defective medical devices are...